COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,762 Articles (22,502 medRxiv, 8,260 bioRxiv)

Most recent first Previous |  Page 1759: Articles 17581-17590  | Next

Is Covid-19 seroprevalence different in health care workers as per their risk of exposure? A study from a tertiary care hospital in National Capital Region of India
Sushila Kataria, Rashmi Phogat, Pooja Sharma, Vikas Deswal, Sazid Alam, Manish Singh, Kuldeep Kumar, Vaibhav Gupta, Padam Singh, Rohit Dutt, Smita Sarma, Renu Saxena, Naresh Trehan
10.1101/2021.02.10.21251543 — Posted: 2021-02-12
County-Specific, Real-Time Projection of the Effect of Business Closures on the COVID-19 Pandemic
Dominic Yurk, Yaser Abu-Mostafa
10.1101/2021.02.10.21251533 — Posted: 2021-02-12
Decline in mitigation readiness facilitated second waves of SARS-CoV-2
Kai Wirtz
10.1101/2021.02.10.21251523 — Posted: 2021-02-12
Antigen-based multiplex strategies to discriminate SARS-CoV-2 natural and vaccine induced immunity from seasonal human coronavirus humoral responses
Eric D. Laing, Spencer L. Sterling, Stephanie A. Richard, Nusrat J. Epsi, Si’Ana Coggins, Emily C. Samuels, Shreshta Phogat, Lianying Yan, Nicole Moreno, Christian L. Coles, Matthew Drew, Jennifer Mehalko, Caroline E. English, Scott Merritt, Katrin Mende, Vincent J. Munster, Emmie de Wit, Kevin K. Chung, Eugene V. Millar, David R. Tribble, Mark P. Simons, Simon D. Pollett, Brian K. Agan, Dominic Esposito, Charlotte Lanteri, G. Travis Clifton, Edward Mitre, Timothy H. Burgess, Christopher C. Broder
10.1101/2021.02.10.21251518 — Posted: 2021-02-12
Screening for SARS-CoV-2 by RT-PCR: saliva or nasopharyngeal swab? Systematic review and meta-analysis
Nusaïbah Ibrahimi, Agnès Delaunay-Moisan, Catherine Hill, Gwénaël Le Teuff, Jean-François Rupprecht, Jean-Yves Thuret, Dan Chaltiel, Marie-Claude Potier
10.1101/2021.02.10.21251508 — Posted: 2021-02-12
Screening plans for SARS-CoV-2 based on sampling and rotation: an example in the school setting
Michela Baccini, Giulia Cereda
10.1101/2021.02.10.21251502 — Posted: 2021-02-12
A robust phenomenological approach to investigate COVID-19 data for France
Q. Griette, J. Demongeot, P. Magal
10.1101/2021.02.10.21251500 — Posted: 2021-02-12
Symptom reporting in over 1 million people: community detection of COVID-19
Joshua Elliott, Matthew Whitaker, Barbara Bodinier, Steven Riley, Helen Ward, Graham Cooke, Ara Darzi, Marc Chadeau-Hyam, Paul Elliott
10.1101/2021.02.10.21251480 — Posted: 2021-02-12
A participatory modelling approach for investigating the spread of COVID-19 in countries of the Eastern Mediterranean Region to support public health decision-making
Keyrellous Adib, Penelope A. Hancock, Aysel Rahimli, Bridget Mugisa, Fayez Abdulrazeq, Noha Farag, Ricardo Aguas, Lisa White, Rana Hajjeh, Lubna Al Ariqi, Pierre Nabeth
10.1101/2021.02.10.21251474 — Posted: 2021-02-12
Correcting excess mortality for pandemic-associated population decreases
Jeremy Samuel Faust, Chengan Du, Shu-Xia Li, Zhenqiu Lin, Harlan M. Krumholz
10.1101/2021.02.10.21251461 — Posted: 2021-02-12

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).